Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Motivation et neurotransmetteurs chez les rameurs

15 septembre 2026 mis à jour par: Poznan University of Physical Education

Corrélats psychobiologiques de la motivation à la performance et réponses des neurotransmetteurs à l'exercice chez les rameurs d'élite

The goal of this observational study is to learn how motivation and body chemistry are linked during and after intense exercise in national-level rowers.

The main questions this study aims to answer are:

Do athletes with higher motivation show different changes in brain chemicals after exercise? How do hormone and neurotransmitter levels change during recovery after exercise?

Participants will:

Complete a motivation questionnaire called the Inventory of Achievement Motivation (LMI) before the exercise test.

Perform a 6000-meter rowing test on an indoor rowing machine. Have blood samples taken three times: before exercise, immediately after exercise, and 1 hour after exercise.

Researchers will measure blood levels of testosterone, cortisol, serotonin, dopamine, beta-endorphin, anandamide (AEA), and 2-arachidonoylglycerol (2-AG).

This study will help researchers understand how motivation and body chemistry work together to influence performance and recovery in highly trained athletes.

Aperçu de l'étude

Statut

Complété

Les conditions

Intervention / Traitement

Description détaillée

This study explores how motivation and body chemistry are connected during and after intense physical exercise in national-level rowers. Researchers want to understand how psychological factors, such as motivation to achieve goals, relate to changes in hormones and brain chemicals that occur with exercise and recovery.

Before the exercise test, participants will complete a motivation questionnaire called the Inventory of Achievement Motivation (LMI). This questionnaire helps identify how strongly a person is driven to perform, overcome challenges, and reach success.

After the questionnaire, each participant will complete a 6000-meter rowing test on an indoor rowing machine. This test is designed to produce a high level of physical effort similar to competition conditions. Blood samples will be taken three times: before the test, immediately after the test, and one hour after recovery.

The blood samples will be used to measure levels of several hormones and neurotransmitters, including testosterone, cortisol, serotonin, dopamine, beta-endorphin, anandamide (AEA), and 2-arachidonoylglycerol (2-AG). These substances are involved in stress response, motivation, reward, and recovery.

Researchers will compare the results from the motivation questionnaire with changes in hormone and neurotransmitter levels. The goal is to find out whether more motivated athletes show different chemical responses to exercise and recovery.

Findings from this study may improve understanding of how the mind and body interact during intense training. This knowledge could help athletes and coaches develop better ways to support motivation, performance, and recovery in high-level sports.

Type d'étude

Observationnel

Inscription (Réel)

24

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Greater Poland Voivodeship
      • Poznan, Greater Poland Voivodeship, Pologne, 61-871
        • Poznań University of Physical Education

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 25 ans (Adulte)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Homme

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

All participants were recruited and tested at the Central Sports Centre - Olympic Preparation Center (COS OPO) in Wałcz, Poland, during a national team training camp under standardized conditions.

La description

Inclusion Criteria:

National-level male rowers Age between 18 and 25 years Minimum of 3 years of systematic rowing training Regular training load (at least 10 sessions per week during the competitive season) Good general health and medical clearance for maximal exercise testing

Exclusion Criteria:

Current illness, injury, or infection Use of medications or dietary supplements that could affect hormone or neurotransmitter levels Smoking or use of psychoactive substances Inadequate sleep or food intake before testing Refusal or inability to provide informed consent

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Modèles d'observation: COHORT
  • Perspectives temporelles: RETROSPECTIVE

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
Rowers

The study includes 24 national-level male rowers. All participants are healthy, highly trained athletes with at least 3 years of systematic rowing experience and regular intensive training.

Participants perform a 6000-meter rowing test on an indoor ergometer at maximal effort to simulate race conditions and induce physiological fatigue.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Changes in serum Cortisol levels
Délai: Before exercise, immediately after, and 1 hour after recovery

Measurement of Cortisol serum concentrations (ng/mL).

Before exercise, immediately after, and 1 hour after recovery
Changes in serum Testosterone levels
Délai: Before exercise, immediately after, and 1 hour after recovery

Measurement of Testosterone serum concentrations (ng/mL).

Before exercise, immediately after, and 1 hour after recovery
Changes in serum Dopamin levels
Délai: Before exercise, immediately after, and 1 hour after recovery

Measurement of Dopamin serum concentrations (ng/mL).

Before exercise, immediately after, and 1 hour after recovery
Changes in serum Serotonin levels
Délai: Before exercise, immediately after, and 1 hour after recovery

Measurement of Serotonin serum concentrations (ng/mL).

Before exercise, immediately after, and 1 hour after recovery
Changes in serum Beta-endorphin levels
Délai: Before exercise, immediately after, and 1 hour after recovery

Measurement of Beta-endorphin serum concentrations (ng/mL).

Before exercise, immediately after, and 1 hour after recovery
Changes in serum anandamide (AEA) levels
Délai: Before exercise, immediately after, and 1 hour after recovery

Measurement of anandamide (AEA) serum concentrations (ng/mL).

Before exercise, immediately after, and 1 hour after recovery
Changes in serum 2-arachidonoylglycerol (2-AG)) levels
Délai: Before exercise, immediately after, and 1 hour after recovery

Measurement of 2-arachidonoylglycerol (2-AG) serum concentrations (ng/mL).

Before exercise, immediately after, and 1 hour after recovery

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Changes in Testosterone-to-cortisol ratio (T:C)
Délai: Before exercise, immediately after, and 1 hour after recovery

Ratio calculated from serum testosterone and cortisol concentrations (ng/mL), used as an indicator of anabolic-catabolic balance.

Before exercise, immediately after, and 1 hour after recovery
Changes in TSerotonin-to-dopamine ratio (S:D)
Délai: Before exercise, immediately after, and 1 hour after recovery

Ratio of serum serotonin to dopamine concentrations (ng/mL), reflecting neurochemical balance related to motivation and fatigue.

Before exercise, immediately after, and 1 hour after recovery
Achievement Motivation (LMI score)
Délai: Before exercise (baseline)

Assessment of achievement motivation using the Inventory of Achievement Motivation (LMI). The questionnaire evaluates multiple dimensions of motivation, such as persistence, confidence in success, goal setting, and compensatory effort. Total and subscale scores are analyzed to identify individual motivational profiles.

Before exercise (baseline)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

1 novembre 2023

Achèvement primaire (Réel)

28 novembre 2023

Achèvement de l'étude (Réel)

2 décembre 2023

Dates d'inscription aux études

Première soumission

14 novembre 2025

Première soumission répondant aux critères de contrôle qualité

14 novembre 2025

Première publication (Réel)

19 novembre 2025

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

18 septembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

15 septembre 2026

Dernière vérification

1 novembre 2025

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • LMI60002023

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

Individual participant data (IPD) will not be shared. Data will be used only for internal analysis and dissemination in scientific publications in aggregate form, in accordance with ethical approval.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .